ASPIRE Cardiovascular, a Pfizer-supported independent competitive grants program, is awarding individual grants of up to $200,000 from a total fund of $2 million to support projects which bring new insights or advance the understanding of the role of the PCSK9 protein/gene in health and disease.

Emerging investigators, within 10 years of their first academic appointment at the level of Assistant Professor/Instructor, or equivalent, are particularly encouraged to apply. The application deadline is March 13. Learn more.

For additional research funding opportunities and resources, visit